MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$3,114K
Net Income
-$7,469K
Net Profit Margin
-239.85%
EPS
-$0.17
Unit: Thousand (K) dollars
Revenue Breakdown
    • Women SHealth
    • Cardiovascular

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net sales
3,114 -3,323 3,323 6,263
Cost of goods sold
1,312 -2,551 1,470 3,205
Gross profit
1,802 -772 1,853 3,058
Sales and marketing
1,480 -2,645 1,601 3,778
General and administrative
4,091 3,995 3,519 3,695
Research and development
1,973 714 1,088 1,456
Litigation costs, net
606 1,070 853 4,004
Total operating expenses
8,150 3,134 7,061 12,933
Loss from continuing operations
-6,348 -3,906 -5,208 -9,875
Interest (income) expense, net
108 97* NaN NaN
Interest expense, net
NaN NaN 265 518
Loss (gain) on revaluation of warrant liability
1,655 -906 -5,098 -2,233
Other (income) expense, net
71 947* NaN -1,442
Loss from continuing operations before provision for income taxes
-7,824 -1,956 -375 -9,602
Income tax expense
70 -11 8 8
Net loss from continuing operations
-7,894 -881* -383 -9,610
Income (loss) from discontinued operations
425 71,673* -3,485 NaN
Net loss
-7,469 70,791 -3,868 -9,610
Less dilutive gain on revaluation of warrant liability
NaN 5,990 NaN 2,233
Net income (loss) attributable to common stockholders
NaN NaN -3,868 NaN
Net loss for dilutive earnings per share
-7,469 64,801 NaN -11,843
Basic EPS
-0.17 1.513 -0.09 -0.23
Diluted EPS
-0.17 1.362 -0.19 -0.26
Basic Average Shares
42,998,504 42,837,323 42,431,314 41,782,556
Diluted Average Shares
42,998,504 47,592,196 46,957,199 46,308,642
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss fordilutive earnings per...-$7,469K (18.23%↑ Y/Y)Net loss-$7,469K (-89.91%↓ Y/Y)Income (loss) fromdiscontinued operations$425K Net loss fromcontinuing operations-$7,894K Women SHealth$2,089K (-20.42%↓ Y/Y)Cardiovascular$1,025K (214.42%↑ Y/Y)Loss from continuingoperations before...-$7,824K (-99.34%↓ Y/Y)Income tax expense$70K (775.00%↑ Y/Y)Interest (income)expense, net$108K Other (income)expense, net$71K (167.62%↑ Y/Y)Net sales$3,114K (-48.36%↓ Y/Y)Loss from continuingoperations-$6,348K (19.87%↑ Y/Y)Loss (gain) onrevaluation of warrant...$1,655K (131.91%↑ Y/Y)Gross profit$1,802K (-26.66%↓ Y/Y)Cost of goods sold$1,312K (-63.28%↓ Y/Y)Total operatingexpenses$8,150K (-21.48%↓ Y/Y)General andadministrative$4,091K (5.68%↑ Y/Y)Research and development$1,973K (118.01%↑ Y/Y)Sales and marketing$1,480K (-51.17%↓ Y/Y)Litigation costs, net$606K (-76.44%↓ Y/Y)

ELUTIA INC. (ELUT)

ELUTIA INC. (ELUT)